Catalyst Pharmaceuticals ...

NASDAQ: CPRX · Real-Time Price · USD
20.23
0.16 (0.80%)
At close: Aug 15, 2025, 3:59 PM
20.15
-0.37%
After-hours: Aug 15, 2025, 07:54 PM EDT

Catalyst Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
163.89M 71.41M 83.08M 39.48M
Depreciation & Amortization
37.77M 32.88M 1.24M 192K
Stock-Based Compensation
22.25M 14.25M 7.91M 6.07M
Other Working Capital
67.91M -330K 15.28M 10.36M
Other Non-Cash Items
-5.63M 80.2M 5.16M 287K
Deferred Income Tax
-9.39M -17.82M 4.94M 9.32M
Change in Working Capital
30.91M -37.32M 13.73M 5.02M
Operating Cash Flow
239.81M 143.6M 116.05M 60.37M
Capital Expenditures
-556K -198.52M -29K -1.02M
Cash Acquisitions
n/a n/a 10M n/a
Purchase of Investments
n/a -13.46M -10M -10M
Sales Maturities Of Investments
n/a n/a 19.24M n/a
Other Investing Acitivies
-293.27M -81.51M -10M -10M
Investing Cash Flow
-556K -293.5M 9.21M -11.02M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -982K -6.91M -12.09M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-39K -10.86M 8.6M 3.95M
Financial Cash Flow
140.66M -10.86M 1.69M -8.14M
Net Cash Flow
379.92M -160.76M 126.95M 41.21M
Free Cash Flow
239.25M -54.92M 116.02M 59.35M